AGŐćČ˹ٷ˝

STOCK TITAN
  1. Home
  2. Sec-filings
  3. AGEN
  4. [SCHEDULE 13G/A] Agenus Inc. SEC Filing

[SCHEDULE 13G/A] Agenus Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Filing content is currently unavailable.

Source:

Stock AGEN logo
Agenus

NASDAQ:AGEN

AGEN Rankings

#4476 Ranked by Market Cap
N/A Ranked by Dividends

AGEN Latest News

Aug 26, 2025
Update: Agenus Aug 27 Stakeholder Webcast—Transformative IO Updates, BOT/BAL Data, BATTMAN Preview, Zydus Partnership Momentum, and MiNK Spotlight
Aug 19, 2025
Agenus to Unveil BOT/BAL Strategic Advancements, Key Milestones, and Future Outlook in Virtual Stakeholder Briefing on August 27, 2025
Aug 11, 2025
Agenus Announces Second Quarter 2025 Financial Results and Virtual Meeting to Discuss Strategic Progress
Jul 31, 2025
Agenus to Provide Corporate Update and Second Quarter 2025 Financial Report
Jul 25, 2025
Agenus to Highlight Emerging Survival Plateaus with Botensilimab/Balstilimab in Oral Presentation of Study in Refractory Patients Across Five Tumor Types at ESMO 2025

AGEN Latest SEC Filings

Aug 26, 2025
[Form 4] Agenus Inc. Insider Trading Activity
Aug 11, 2025
[10-Q] Agenus Inc. Quarterly Earnings Report
Aug 11, 2025
[Form 4] Agenus Inc. Insider Trading Activity
Aug 11, 2025
[8-K] Agenus Inc. Reports Material Event
Jul 29, 2025
[SCHEDULE 13G/A] Agenus Inc. SEC Filing

AGEN Stock Data

139.88M
31.33M
1.68%
30.1%
9.18%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
LEXINGTON